The accompanying drawings, which are incorporated in and form a part of the specification, illustrate the various embodiments of the present invention, and together with the description, serve to explain the principles of the invention.
Reference will now be made in detail to the present preferred embodiment of the invention, an example of which is illustrated in the accompanying drawings.
A preferred embodiment of the present invention comprises a nerve stimulator function that allows control of the current output through a fingertip control on the stimulating needle. A preferred embodiment of the needle assembly of the present invention is illustrated in
The housing unit 102 also preferably contains an embedded fluid path 110 through which fluid from a tube 109 may flow to a needle 107. The tube 109 may be any tube suitable for carrying fluids such as a plastic injection tube. The tube 109 may be formed within the housing unit 102 or may mate with the housing unit 102 via known techniques of mating tubes. Needle 107 is preferably inserted into a cavity (not shown) in the housing unit 102 so that it mates with the embedded fluid path 110. Needle 107 may be detachable from housing 102 or may be permanently affixed to housing 102. Those of skill in the art will appreciate that the tube 109 and the needle 107 should be attached to the embedded fluid path 110 according to techniques known in the art in a manner that avoids leakage of the fluid and also avoids contamination of the fluid. The hypodermic needle preferably consists of stainless steel, and is preferably coated with an insulation layer 108, although a needle without the insulation layer may be used but may provide less efficient current transfer to the nerve. The needle tip is preferably not coated with the insulation layer and the needle tip may be of any type of bevel, such as a short or a long bevel. The insulation layer 108 is preferably a biocompatible insulation layer and preferably comprised of Teflon, polyethylene, PVC, polypropylene, or any other suitable material.
A variable control mechanism 101 for variably controlling the current applied to needle 107 may include any type of finger actionable switch, such as a rocker switch, pressure switch, slider switch or any other known finger actionable switch, attached to the housing unit 102. A voltage may be applied from a voltage source 180 to the variable control mechanism 101 via an electrical pin connector 103 and electrical trace 140 in the housing unit 102 and reduced or increased depending on the operation of the variable control mechanism 101. The output voltage on the variable control mechanism 101 is directed to a control device 181, via a second electrical pin connector 104, for processing and determining the output current to be delivered from a current source 182 via the third electrical pin connector 105 to the embedded hypodermic needle 107. The current provided by the current source 182 is preferably in the form of a pulse train as known in the art.
As the needle is advanced through the skin surface 136, the nerve stimulator 131 is activated and controlled by the variable control mechanism 101 via the current output control cable 142 attached to the nerve stimulator 131 by electrical pin connector 130. The output current is supplied through electrical pin connector 127 via an electrical cable 122 to electrical pin connector 105 on the housing unit 102. Voltage is output through electrical pin connector 129 via electrical cable 126 to electrical pin connector 103 on the housing unit 102 for output current control. The electrical return electrode 135 bears a connector 134 that attaches via an electrical cable 123 to an electrical pin connector 128 on the nerve stimulator 131. The return electrode 135 is typically a silver-silver chloride electrocardiographic electrode. The operator is able to determine the proximity of the needle tip to the nerve by observation of a visible twitch stimulated in the muscle supplied by the target nerve. In a nerve stimulator operation, current is supplied to the hypodermic needle 107 at a level of 1-2 mA and the needle advanced until muscle twitch is achieved. By following appropriate muscle twitches, the amplitude of the current output may be gradually decreased by the use of the variable control mechanism 101 until twitch is observed at less than 0.5 mA as shown on display 141. When the needle tip position is an appropriate distance from the nerve, e.g., 1-2 mA at a current output of less than 0.5 mA, the operator injects the solution in the syringe. This process, using a nerve stimulator needle of the prior art, is generally described in U.S. Pat. No. 5,830,151 to Hadzic et al. A second embodiment of the present invention is illustrated in
The needle 107 shown in
The needle of the second embodiment also may be used with the nerve stimulator 131′ shown in
Existing nerve stimulators are designed to deliver constant current pulses for nerve stimulation purposes. These devices do not provide constant current (a constant non pulsed current). However, one of skill in the art is able to readily design a constant current source 190, and the circuit design may be analogous to that for producing the constant current pulse for stimulation. The nerve stimulator 131′ described herein preferably contains two separate current sources, one of which, the constant current source 182, is adjustable by the user for stimulation pulse generation, i.e. pulse current i. The other of which, the constant current voltage source 190, is not adjustable by the user and provides a constant current (I) to the linear resistance coating 106.
By way of example, as shown in
The resistance of the linear resistance coating 106 is constant per unit length and significantly higher than that of tissue, which is on the order of 1.0 megaohm per mm. Tissue impedance is typically in the range of 0.1-1.0 kilohms. Since the tissue impedance is less than the resistance of any portion of the needle by orders of magnitude, the resistance of the circuit is approximately that of the needle coating alone. The total resistance (Rt) of the needle linear resistance coating 106 is the product of the resistance per unit length (rL) and the length of the needle (Lt). As the needle is advanced through the skin, Rt t may be represented as the sum of the length protruding above the skin (Lb) 137 multiplied by rL and of the length beneath the skin (Lb) 138 multiplied by rL, as given in equation 1.
R
t
=r
L
×L
t=(rL×La)+(rL×Lb) Eq. 1
Therefore, since the resistance determined by the nerve stimulator 131′ in this circuit is directly related to the length of the coating that protrudes above the skin surface (Ra=rL×La), the length of the needle below the skin surface may be determined by equation 2.
L
b=(Rt−Ra)/rL Eq. 2
where Ra is the resistance of the portion of the needle protruding above the skin. Since Rt and rL are known and Ra is calculated directly from the ratio of the measured voltage to the applied current (Ohm's Law: V=IR), Lb may be calculated. If the needle is inserted to the point that the housing unit 102 contacts the skin surface, La=0, the measured resistance is that of the tissue alone, and thus Lb=Lt in that situation.
In its simplest form, the resistive layer may be a wire glued to the length of the needle. The wire may be comprised of, for example, carbon (graphite), nichrome, or any material that yields a resistance that may be differentiated adequately from the tissue impedance of the system. For example, for a desired resistance R of 100 kohm/cm, the following equation 3 allows determination of the cross sectional area of a desirable circular wire.
R=ρ×(L/A), Eq. 3
where: R=resistance in ohms; ρ=resistivity in ohm-cm; L=length in cm; and A=cross sectional area in cm2.
The following is based upon a resistance R of approximately 100 kohms. For nichrome, with a resistivity of 100 μohm-cm and L of 1 cm, A would be 10−9 cm2; the diameter of the wire would be 0.35 micron. For graphite, with a resistivity of 1375 μohm-cm and L of 1 cm, A would be 1.375×10−8 cm2; the diameter of the wire would be 1.32 micron. The resistive layers can be applied to the needle by any number of medical grade adhesives. The resistive layer applied to the needle need not be a cylindrical wire, but may be material that is flattened, is screen printed in a desired conformation, or that circumferentially coats the needle. Further, the resistive layer may be a type of resistive coating, such as an organic coating with the desired resistivity properties.
The return electrode 135 is used for both stimulator current control and for needle depth determination through the measurement of resistance.
In step S4, the microprocessor determines the decay time t of the current pulse in the tissue of the subject as t=5RC. Particularly, for a circuit containing a parallel resistance (R) and capacitance (C), such as biological tissue, a tissue time constant may be calculated from the product of R and C. When subjected to a current pulse, the capacitive element of such a circuit charges over a defined time interval. On termination of the current pulse, this capacitive element discharges over a characteristic time interval, which follows an exponential decay curve, which takes about five tissue time constants (5RC) to reach 99% of the final value. This is described in more detail by Nunn (Nunn J F, Applied Respiratory Physiology, Butterworths, London, 1977, p. 464-469) and Horowitz and Hill (Horowitz P and Hill W, The Art of Electronics, Cambridge University Press, Cambridge, Mass., 1986, p. 20-21). Since tissue time constants are in the range of 1 msec or less, allowing greater than 5 msec to pass following the termination of the stimulating pulse provides adequate time for the measured voltage to approximate baseline values of the voltage applied to the resistive layer. Alternatively, t may set to a value greater than or equal to 5 msec.
At step S6, the microprocessor waits for the time t to elapse since the end of the current pulse i (No in step 6). Once the time t has elapsed (Yes in step 6), the measured voltage from return electrode 135 via voltmeter 145 is used to calculate Ra (step S8). The needle depth Lb is then calculate in step S10 according to equation 2, and displayed in step S12. The calculated value of Lb may then be visually displayed on display 141. Those of skill in the art will appreciate that the calculated value Lb may also be audibly displayed and/or may be printed by a printing device attached either directly or indirectly to nerve stimulator 131′.
A third embodiment is shown in
A fourth embodiment of the invention is illustrated in
The operation of this embodiment is illustrated in
The foregoing description of a preferred embodiment of the invention has been presented for purposes of illustration and description. It is not intended to be exhaustive or to limit the invention to the precise form disclosed, and obviously many modifications and variations are possible in light of the above teaching. For example, although the method of
This application is a continuation-in-part of U.S. patent application Ser. No. 10/772,397, filed on Feb. 5, 2004 which is a divisional of U.S. patent application Ser. No. 09/989,206 filed on Nov. 21, 2001, now U.S. Pat. No. 6,706,016 issued Mar. 16, 2004, which claims priority to U.S. provisional application 60/253,064 filed on Nov. 24, 2000, each of the contents of which are herein incorporated by reference.
| Number | Date | Country | |
|---|---|---|---|
| 60253064 | Nov 2000 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 09989206 | Nov 2001 | US |
| Child | 10772397 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 10772397 | Feb 2004 | US |
| Child | 11385680 | US |